+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Single-Photon Emission Computed Tomography (SPECT) Market 2020-2024

  • PDF Icon

    Report

  • 120 Pages
  • November 2020
  • Region: Global
  • TechNavio
  • ID: 5212589
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Global Single-Photon Emission Computed Tomography (SPECT) Market 2020-2024

The publisher has been monitoring the single-photon emission computed tomography (SPECT) market and it is poised to grow by $ 620.21 mn during 2020-2024, progressing at a CAGR of 6% during the forecast period. The reports on the single-photon emission computed tomography (SPECT) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the growing adoption of SPECT/CT hybrid imaging systems and the rise in the prevalence of chronic disorders. In addition, the growing adoption of SPECT/CT hybrid imaging systems is anticipated to boost the growth of the market as well.

The single-photon emission computed tomography (SPECT) market analysis includes product segment, application segment and geographical landscapes.

The single-photon emission computed tomography (SPECT) market is segmented as below:

By Product
  • Standalone SPECT
  • Hybrid SPECT

By Application
  • Cardiology
  • Oncology
  • Neurology
  • Others

By Geographical Landscapes
  • North America
  • Europe
  • Asia
  • ROW

This study identifies the increased use of nuclear medicine for detecting diseases at an early stage as one of the prime reasons driving the single-photon emission computed tomography (SPECT) market growth during the next few years.

The single-photon emission computed tomography (SPECT) market report covers the following areas:
  • Single-photon emission computed tomography (SPECT) market sizing
  • Single-photon emission computed tomography (SPECT) market forecast
  • Single-photon emission computed tomography (SPECT) market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading single-photon emission computed tomography (SPECT) market vendors that include Bruker Corp., DDD-Diagnostic AS, Digirad Corp., General Electric Co., Koninklijke Philips NV, Mediso Ltd., MiE GmbH, MILabs BV, Siemens Healthineers AG, and Spectrum Dynamics Medical Inc. Also, the single-photon emission computed tomography (SPECT) market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents

Executive Summary
  • Market Overview

Market Landscape
  • Market ecosystem
  • Market characteristics
  • Value chain analysis

Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis
  • Five forces analysis 2019 & 2024
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Product
  • Market segments
  • Comparison by Product
  • Standalone SPECT - Market size and forecast 2019-2024
  • Hybrid SPECT - Market size and forecast 2019-2024
  • Market opportunity by Product

Market Segmentation by Application
  • Market segments
  • Comparison by Application
  • Cardiology - Market size and forecast 2019-2024
  • Oncology - Market size and forecast 2019-2024
  • Neurology - Market size and forecast 2019-2024
  • Others - Market size and forecast 2019-2024
  • Market opportunity by Application

Customer landscape
  • Overview

Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape
  • Overview
  • Landscape disruption
  • Competitive scenario

Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • Bruker Corp.
  • DDD-Diagnostic AS
  • Digirad Corp.
  • General Electric Co.
  • Koninklijke Philips NV
  • Mediso Ltd.
  • MiE GmbH
  • MILabs BV
  • Siemens Healthineers AG
  • Spectrum Dynamics Medical Inc.

Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

List of Exhibit
  • Key Finding 1
  • Key Finding 2
  • Key Finding 3
  • Key Finding 5
  • Key Finding 6
  • Key Finding 7
  • Key Finding 8
  • Key Finding 9
  • Parent market
  • Market characteristics
  • Offerings of vendors included in the market definition
  • Market segments
  • Global - Market size and forecast 2019 - 2024 ($ million)
  • Global market: Year-over-year growth 2019 - 2024 (%)
  • Five forces analysis 2019 & 2024
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition - Five forces 2019
  • Product - Market share 2019-2024 (%)
  • Comparison by Product
  • Standalone SPECT - Market size and forecast 2019-2024 ($ million)
  • Standalone SPECT - Year-over-year growth 2019-2024 (%)
  • Hybrid SPECT - Market size and forecast 2019-2024 ($ million)
  • Hybrid SPECT - Year-over-year growth 2019-2024 (%)
  • Market opportunity by Product
  • Application - Market share 2019-2024 (%)
  • Comparison by Application
  • Cardiology - Market size and forecast 2019-2024 ($ million)
  • Cardiology - Year-over-year growth 2019-2024 (%)
  • Oncology - Market size and forecast 2019-2024 ($ million)
  • Oncology - Year-over-year growth 2019-2024 (%)
  • Neurology - Market size and forecast 2019-2024 ($ million)
  • Neurology - Year-over-year growth 2019-2024 (%)
  • Others - Market size and forecast 2019-2024 ($ million)
  • Others - Year-over-year growth 2019-2024 (%)
  • Market opportunity by Application
  • Customer landscape
  • Market share by geography 2019-2024 (%)
  • Geographic comparison
  • North America - Market size and forecast 2019-2024 ($ million)
  • North America - Year-over-year growth 2019-2024 (%)
  • Europe - Market size and forecast 2019-2024 ($ million)
  • Europe - Year-over-year growth 2019-2024 (%)
  • Asia - Market size and forecast 2019-2024 ($ million)
  • Asia - Year-over-year growth 2019-2024 (%)
  • ROW - Market size and forecast 2019-2024 ($ million)
  • ROW - Year-over-year growth 2019-2024 (%)
  • Key leading countries
  • Market opportunity by geography ($ million)
  • Impact of drivers and challenges
  • Vendor landscape
  • Landscape disruption
  • Industry risks
  • Vendors covered
  • Market positioning of vendors
  • Bruker Corp. - Overview
  • Bruker Corp. - Business segments
  • Bruker Corp. - Key offerings
  • Bruker Corp. - Key customers
  • Bruker Corp. - Segment focus
  • DDD-Diagnostic AS - Overview
  • DDD-Diagnostic AS - Product and service
  • DDD-Diagnostic AS - Key offerings
  • DDD-Diagnostic AS - Key customers
  • DDD-Diagnostic AS - Segment focus
  • Digirad Corp. - Overview
  • Digirad Corp. - Business segments
  • Digirad Corp. - Key offerings
  • Digirad Corp. - Key customers
  • Digirad Corp. - Segment focus
  • General Electric Co. - Overview
  • General Electric Co. - Business segments
  • General Electric Co. - Key offerings
  • General Electric Co. - Key customers
  • General Electric Co. - Segment focus
  • Koninklijke Philips NV - Overview
  • Koninklijke Philips NV - Business segments
  • Koninklijke Philips NV - Key offerings
  • Koninklijke Philips NV - Key customers
  • Koninklijke Philips NV - Segment focus
  • Mediso Ltd. - Overview
  • Mediso Ltd. - Product and service
  • Mediso Ltd. - Key offerings
  • Mediso Ltd. - Key customers
  • Mediso Ltd. - Segment focus
  • MiE GmbH - Overview
  • MiE GmbH - Product and service
  • MiE GmbH - Key offerings
  • MiE GmbH - Key customers
  • MiE GmbH - Segment focus
  • MILabs BV - Overview
  • MILabs BV - Product and service
  • MILabs BV - Key offerings
  • MILabs BV - Key customers
  • MILabs BV - Segment focus
  • Siemens Healthineers AG - Overview
  • Siemens Healthineers AG - Business segments
  • Siemens Healthineers AG - Key offerings
  • Siemens Healthineers AG - Key customers
  • Siemens Healthineers AG - Segment focus
  • Spectrum Dynamics Medical Inc. - Overview
  • Spectrum Dynamics Medical Inc. - Product and service
  • Spectrum Dynamics Medical Inc. - Key offerings
  • Spectrum Dynamics Medical Inc. - Key customers
  • Spectrum Dynamics Medical Inc. - Segment focus
  • Currency conversion rates for US$
  • Research Methodology
  • Validation techniques employed for market sizing
  • Information sources
  • List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global single-photon emission computed tomography (spect) market: Bruker Corp., DDD-Diagnostic AS, Digirad Corp., General Electric Co., Koninklijke Philips NV, Mediso Ltd., MiE GmbH, MILabs BV, Siemens Healthineers AG, and Spectrum Dynamics Medical Inc.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is increased use of nuclear medicine for detecting diseases at an early stage.'

According to the report, one of the major drivers for this market is the growing adoption of spect/ct hybrid imaging systems.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Bruker Corp.
  • DDD-Diagnostic AS
  • Digirad Corp.
  • General Electric Co.
  • Koninklijke Philips NV
  • Mediso Ltd.
  • MiE GmbH
  • MILabs BV
  • Siemens Healthineers AG
  • Spectrum Dynamics Medical Inc.